SCHEMBL8092632

SCHEMBL8092632

CCNC(=O)Cc1cc[nH]c(=O)c1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.47
POLB P06746 3/20 0.46
TSHR P16473 2/20 0.43
ALDH1A1 P00352 2/20 0.43
USP2 O75604 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MEN1 O00255 2/20 0.41
NPC1 O15118 2/20 0.41
KMT2A Q03164 2/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.40
KDM4E B2RXH2 3/20 0.40
GAA P10253 3/20 0.40
LMNA P02545 2/20 0.40
HPGD P15428 2/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
BLM P54132 1/20 0.40
ADORA2A P29274 1/20 0.39
NSD2 O96028 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11068271 0.91 POLB (0.44) BRD4POLBTSHRALDH1A1USP2
SCHEMBL11080831 0.89 HPGD (0.43) POLBTSHRALDH1A1USP2HSD17B10
SCHEMBL10963748 0.83 POLB (0.50) BRD4POLBTSHRALDH1A1USP2
SCHEMBL10964174 0.76 PTGER4 (0.55) POLBL3MBTL1THRBNSD2ABL1
SCHEMBL8613427 0.74 POLB (0.41) BRD4POLBTSHRALDH1A1USP2
SCHEMBL10591282 0.72 POLB (0.52) POLBTSHRALDH1A1USP2HSD17B10
SCHEMBL9513587 0.70 POLB (0.50) POLBTSHRALDH1A1USP2HSD17B10
SCHEMBL1095091 0.69 MEN1 (0.61) POLBALDH1A1MEN1NPC1KMT2A
Hydrochloric Acid SCHEMBL15995564 0.68 MEN1 (0.59) POLBALDH1A1MEN1NPC1KMT2A
SCHEMBL5092381 0.67 GAA (0.67) POLBALDH1A1MEN1NPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36831-E TREATMENT OF IRON DEFICIENCY ANEMIA BRITISH TECHNOLOGY GROUP LTD. (GB) 2000-08-22 US disclosed
US-RE35948-E TREATING TOXIC METAL CONCENTRATION BY ADMINISTERING N-SUBSTITUTED 3-HYDROXYPYRID-2-ONE OR 3-HYDROXYPYRID-4-ONE BRITISH TECHNOLOGY GROUP LTD. (GB) 1998-11-03 US disclosed
EP-0305646-A2 3-Hydroxypyrid-4-ones and pharmaceutical compositions BTG INTERNATIONAL LIMITED (GB) 1989-03-08 EP disclosed
US-4650793-A NITROGEN-SUBSTITUTED NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-03-17 US disclosed
US-4585780-A CHELATION OF HEAVY METALS IN BLOOD NATIONAL RESEARCH DEVELOPMENT CORP. (GB) 1986-04-29 US disclosed
EP-0120669-A2 Hydroxypyridones, and their pharmaceutical compositions NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-10-03 EP disclosed
EP-0120670-A1 Iron III complexes of hydroxypyridones, and their pharmaceutical compositions NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-10-03 EP disclosed